Liposaccharides and Capsules of the HAP Group Bacteria

  • B. Fenwick


As with other Gram-negative bacteria, the liposaccharides (LS) and capsules of the organisms of the Haemophilus, Actinohacillus, and Pasteurella (HAP) group serve as the principal interface between the organism and the environment, As such, they play a fundamental role in determining an organism’s pathogenic potential, Understanding the interactions between the bacterium and its environment at a structure/function level as well as those factors which provide a protective rather than destructive host response is important in improving our ability to limit these organisms’ potential to cause disease.


Haemophilus Influenzae Conjugate Vaccine Capsular Polysaccharide Capsular Type Avian Strain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abeck, D., and Korting, H.C., 1992, Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid, Acta, Derrn, Venereol, Suppl, Stockh, 174: 1.Google Scholar
  2. Abu-Kaik, Y., McLaughlin, R.E., Apicella, M.A., and Sinola, S.M., 1991, Analysis of Haemophilus influenzae type b lipooligosaccharide-synthesis gene that assemble or expose a 2-keto-3-deoxyoctulosonic acid epitope, Mol, Microbiol, 5: 2475.CrossRefGoogle Scholar
  3. Afzal, M., Muneer, R., and Akhtar, S., 1992, Serological evaluation of Pasteurella multocida antigens associated with protection in buffalo calves, Rev, Sci, Tech, 11: 917.Google Scholar
  4. Alfa, M.J., Olson, N., Degagne, P., Plummer, F., Namaara, W., Maclean, I., and Ronald, A.R., 1993, Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi, J, Infect, Dis, 167: 1206.CrossRefGoogle Scholar
  5. Ali, Q., Davies, R.L., Parton, R., Coote, J.G., and Gibbs, H.A., 1992, Lipopolysaccharide heterogeneity in Pasteurella haemolytica isolates from cattle and sheep, J, Gen, Microbiol, 138: 2185.CrossRefGoogle Scholar
  6. Altman, E., Perry, M.B., and Brisson, J.R., 1989, Structure of the lipopolysaccharide antigenic 0-chain produced by Actinobacillus pleuropneumoniae serotype 4, Carbohydr, Res, 191: 295.CrossRefGoogle Scholar
  7. Altman, E., Brisson, J.R., and Perry, M.B., 1990, Structural characterization of the capsular polysaccharide and 0-chain of the lipopolysaccharide of Actinobacillus pleuropneumoniae serotype B (strain 405), Can, J, Chem, 68: 329.CrossRefGoogle Scholar
  8. Arditi, M., Ables, L., and Yogev, R., 1989, Cerebrospinal fluid endotoxin levels in children with H, influenzae meningitis before and after administration of intravenous ceftriaxone, J, Infect, Dis, 160: 1005.CrossRefGoogle Scholar
  9. Arditi, M., Kabat, W., and Yogev, R., 1993, Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood, Infect, Dis, 167: 240.CrossRefGoogle Scholar
  10. Austin, F.W., Corstvet, R.E., Schnorr, K.L., and Todd, W.J., 1992, A characterization of monoclonal antibodies prepared against Pasteurella haemolytica serotype 1 surface antigens, Vet, Microbiol, 32: 327.CrossRefGoogle Scholar
  11. Austin, F.W., and Corstvet, R.E., 1993, Purification of a Pasteurella haemolytica serotype 1-specific polysaccharide epitope by use of monoclonal antibody immunoaffinity, Am, J, Vet, Res, 54: 695.Google Scholar
  12. Barbour, M.L., Booy, R., Crook, D.W., Griffiths, H., Chapel, H.M., Moxon, E.R., and Mayon-White, D., 1993, Haemophilus influenzae type h carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine, Pediat, Infect, Dis, J, 12: 478.Google Scholar
  13. Belanger, M., Dubreuil, D., Harel, J., Girard, C., and Jacques, M., 1990, Role of lipopolysaccharides in adherence of Actinobacillus pleuropneumoniae to porcine tracheal rings, infect, Immun, 58: 3523.Google Scholar
  14. Belanger, M., Rioux, S., Foiry, B., and Jacques, M., 1992, Affinity for porcine respiratory tract mucus is found in some isolates of Actinobacillus pleuropneumoniae, FEMS Microbiol, Lett, 97: 119.CrossRefGoogle Scholar
  15. Belanger, M., Dubreuil, D., and Jacques, M., 1994, Proteins found within porcine respiratory tract secretions bind lipopolysaccharides of Actinobacillus pleuropneumoniae, Infect, Immun, 62: 868.Google Scholar
  16. Beynon, L.M., Moreau, M., Richards, J.C., and Perry, M.B., 1991a, Structure of the 0-antigen of Actinobacillus pleuropneumoniae, Carbohydr, Res, 209: 225.CrossRefGoogle Scholar
  17. Beynon, L.M., Perry, M.B., Richards, J.C., 1991h, Structure of the 0-antigen of Actinobacillus pleuropneumoniae serotype 121ipopolysaccharide, Can, J, Chem, 69: 218.CrossRefGoogle Scholar
  18. Beynon, L.M., Griffith, D.W., Richards, J.C., and Perry, M.B., 1992, Characterization of the lipopolysaccharide O antigens of Actinobacillus pleuropneumoniae serotypes 9 and 11: antigenic relationships among serotypes 9, 11, and 1, Bacteriol, 174: 5324.Google Scholar
  19. Binger, E., Goury, V., Bennani, H., Lambert-Zechovsky, N., Aujard, Y., and Darbord, J.C., 1992, Bactericidal activity of beta-lactams and amikacin against Haemophilus influenzae: effect on endotoxin releas, J, Antimicrob, Chemother, 30: 165.CrossRefGoogle Scholar
  20. Bowersock, T.L., Walker, R.D., Maddux, J.M., Fenner, D., and Moore, R.N., 1990, Hematological changes in calves exposed to a mixture of lipopolysaccharide and crude leukotoxin of Pasteurella haemolytica, Can, J, Vet, Res, 54: 425.Google Scholar
  21. Breider, M.A., Kumar, S., and Corstvet, R.E., 1990, Bovine pulmonary endothelial cell damage mediated by Pasteurella haemolytica pathogenic factors, Infect, Immun, 58: 1671.Google Scholar
  22. Breider, M.A., Kumar, S., and Corstvet, R.E., 1991 a, Interaction of bovine neutrophils in Pasteurella haemolytica mediated damage to pulmonary endothelial cells, Vet, Immun, Inmunopath, 27: 337.Google Scholar
  23. Breider, M.A., Kumar, S., and Corstvet, R.E., 199 1h, Protective role of bovine neutrophils in Pasteurella haemolytica-mediated endothelial cell damage, Infect, Immun, 59: 4570.Google Scholar
  24. Brogden, K.A., Adlam, K.A., Lehmkuhl, H.D., Cutlip, R.C., Knights, J.M., and Engen, R.L., 1989, Effect of Pasteurella haemolytica (A 1) capsular polysaccharide on sheep lung in vivo and on pulmonary surfactant in vino, Am.1, Vet, Res, 50: 555.Google Scholar
  25. Brophy, L.N., Kroll, J.S., Ferguson, D.F., and Moxon, E.R., 1991, Capsulation gene loss and ‘rescue’ mutations during the Cap+ to Cap-transition in Haemophilus influenzae type b, J, Gen, Microbiol, 137: 2571.CrossRefGoogle Scholar
  26. Burroughs, M., Cabellos, C., Prasad, S., and Tuomanen, E., 1992, Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gram-negative meningitis?, J, Infect, Dis, 165: S82.CrossRefGoogle Scholar
  27. Burroughs, M., Prasad, S., Cabellos, C., Mendelman, P.M., and Tuomanen, E., 1993, The biologic activities of peptidoglycan in experimental Haemophilus influen:ae meningitis, J, Infect, Dis, 167: 464CrossRefGoogle Scholar
  28. Byrd, W., and Kadis, S., 1989, Structures and sugar compositions of lipopolysaccharides isolated from seven Actinobacillus pleuropneumoniae semtypes, Infect, immun, 57: 3901.Google Scholar
  29. Byrd, W., and Kadis, S., 1992, Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants, Infect, Immun, 60: 3042.Google Scholar
  30. Byrd, W., Harmon B.G., and Kadis, S., 1992, Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae, Vet, Imrnunol, Immunopathol, 34: 307.CrossRefGoogle Scholar
  31. Campagnari, A.A., Spinola, S.M., Lesse, A.J., Kwaik, Y.A., Mandell, R.E., and Apicella, M.A., 1990, Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosa pathogens, Microb, Pathog, 8: 353.CrossRefGoogle Scholar
  32. Campagnari, A.A., Wild, L.M., Griffiths, G.E., Karalus, R.I, Wirth, M.A., and Spinola, S.M., 1991, Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi, Infect, Immun, 59: 2601.Google Scholar
  33. Campagnari, A.A., Karalus, R., Apicella, M., Melaugh, W., Lesse, A.J., and Gibson, B.W., 1994, Use of pyrocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis, Infect, Immun, 62: 2379.Google Scholar
  34. Car, B.D., Slauson, D.O., Suyemoto, M.M., Dore, M., and Neilson, N.R., 1991, Expression and kinetics of induced procoagulant activity in bovine pulmonary alveolar macrophages, Exp, Lung, Res, 17: 939.CrossRefGoogle Scholar
  35. Clementsen, P., Milman, N., Kilian, M., Fomsgaard, A., Back, L., and Nom, S., 1990, Endotoxin from Haemophilus influen:ae enhances IgE-mediated and non-immunological histamine release, Allergy 45: 10.PubMedCrossRefGoogle Scholar
  36. Confer, A.W., Durham, J.A., and Clarke, C.R., 1992, Comparison of antigens of Pasteurella homeolvtica serotype 1 grown in vitro and in vivo, Am.I, Vet, Res, 53: 472.Google Scholar
  37. Confer, A.W., and Durham, J.A., 1992, Sequential development of antigens and toxins of Pasteurella haemolytica serotype 1 grown in cell culture medium, Am.1, Vet, Res, 53: 646.Google Scholar
  38. Cook, G., Wilson, R., Kroll, S., Todd, H., Garbett, N., Moxon, R., and Cole, P., 1989, Opsonic requirements and interaction of Haemophilus influen:ae with human polymorphonuclear neutrophil leukocytes studied by luminol-enhanced chemiluminescence, Micro, Pathog, 7: 101.CrossRefGoogle Scholar
  39. Cope, L.D, Yogev, R., Mertsola, J., Argyle, J.C., McCracken Jr., G.H., and Hansen, E.J., 1990, Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b, Infect, Immun, 58: 2343.Google Scholar
  40. Cope, L.D., Yogev, R., Maertsola, J., Latimer, J.L., Hanson, M.S., McCracken Jr., G.H., and Hansen, E.J., 1991, Molecular cloning of a gene involved in lipooligosaccharide biosynthesis and virulence expression by Haemophilus influenzae type B, Mol, Micorbiol, 5: 1113.CrossRefGoogle Scholar
  41. Corn, P.G., Anders, J., Takala, A.K., Kayhty, H., and Hoiseth, S.K., 1993, Genes involved in Haemophilia influenzae type b capsule expression are frequently amplified, J, Infect, Dis, 167: 356.CrossRefGoogle Scholar
  42. Cundell, D.R., Taylor, G.W., Kanthakumar, K., Wilks, M., Tabagchall, S., Dorey, E., Devalia, J.L., Roberts, D.E., Davies, R.J., R, Wilson, and Cole, P.J., 1993, Inhibition of human neutrophil migration in vitro by low-molecular-mass products lof nontypeable Ilaemophilus influenzae, infect, Immun, 61: 2419.Google Scholar
  43. Czuprynski, C.J., Noel, E.J., and Adlam, C., 1991, Pasteurella haemolytica Al purified capsular polysaccharide do not stimulant interleukin-1 and tumor necrosis factor release by bovine monocyte and alveolar macrophages, Vet, Immun, TrmnuWopath, 28: 157.Google Scholar
  44. Davies, R.L., Ali, Q., Parton, R., Coote, J.G., Gibbs, A., and Freer, J.H., 1991, Optimal conditions for the analysis of Pasteurella haemolytica lipopolysaccharide by sodium dodecyl sulphate-polyacrylamide gel electrophoresis, FEMS Microbial, Lett 69: 23.CrossRefGoogle Scholar
  45. Davies, R.L., Parton, R., Coote, J.G., Gibbs, A., and Freer, J.H., 1992, Outer-membrane protein and lipopolysaccharide variation in Pasteurella haemolytica serotype Al under different growth conditions, J, Gen, Microbial, 138: 909.CrossRefGoogle Scholar
  46. Dubreuil, J.D., Gilbert, L., and Jacques, M., 1992, Cell surface characteristics and virulence in mice of Pasteurella multocida, Zentralblati fur Bacteriol, 276: 366.CrossRefGoogle Scholar
  47. Fenwick, B.W., and Osburn, B.i., 1986a, Isolation and biologic characterization of two lipopolysaccharides and a capsular enriched polysaccharide fraction isolated from Haemophilus pleuropneumoniae, Am, J, Vet, Med, Res, 47: 1433.Google Scholar
  48. Fenwick, B.W., and Osburn, B.I., 1986b, Immune responses to the lipopolysaccharides and capsular polysaccharides of Haemophilus pleuropneumoniae in convalescent and immunized pigs, Infect, Immun, 54: 575.Google Scholar
  49. Fenwick, B.W„ and Osburn, B.L, 1986e, Vaccine potential of Haemophilus pleuropneumoniae oligosaccharide tetanus-toxoid conjugates, Infect, Immun, 54: 583.Google Scholar
  50. Fenwick, B.W., Cullor, J.S., Osburn, B.I., and Olander, H., 1986a, Mechanisms involved in the protection provided by immunization against core lipopolysaccharides of E, Coli (J5) from lethal Haemophilus pleuropneumoniae infections in swine, Infect, Immun, 53: 298–304.Google Scholar
  51. Fenwick, B.W., Osburn, B.I., and Olander, H.J., 1986b, Resistance of C3H/HeJ Mice to the effects of Haemophilus pleuropneumoniae, Infect, Immun, 53: 474.Google Scholar
  52. Fenwick, B.W., 1990, Virulence attributes of the lipopolysaccharides of the HAP group Organisms, Can, J, Vet, Res, 54: S28.Google Scholar
  53. Ficken, M.D., Barnes, H.J., Avakian, A.P., and Canner, D.K., 1992a, Vaccination of turkeys with cell-free culture filtrates of Pasteurella multocida: effects of dilution, iron chelation, and heterologous challenge, Avian Dis, 36: 975.PubMedCrossRefGoogle Scholar
  54. Ficken, M.D., Barnes, H.J., Avakian, A.P., and Carver, D.K., 1992h, Vaccination of turkeys with cell-free culture filtrate of Pasteurella multocida: effect of ultrafiltration and endotoxin removal, Avian Dis, 36: 423.PubMedCrossRefGoogle Scholar
  55. Frosch, M., Edwards, U., Bousset, K., Krausse, B., and Weisgerber, C., 1991, Evidence for a common molecular origin of the capsule gene loci in gram-negative bacteria expressing group II capsular polysaccharides, Mol, Microbiol, 5: 1251.CrossRefGoogle Scholar
  56. Graham, L.L., Harris, R., Villiger, W., and Bevenridge, T.J., 1991, Freeze-substitution of gram-negative eubacteria: general cell morphology and envelope profiles, Bacteriol, 173: 1623.Google Scholar
  57. Hansen, L.M., and Hirsh, D.C., 1989, Serum resistance is correlated with encapsulation of avian strains of Pasteurella multocida, Vet, Microbiol, 21: 177.CrossRefGoogle Scholar
  58. Harmon, B.G., Glisson, J.R., Latimer, K.S., Steffens, W.L., and Nunnally, J.C., 1991, Resistance of Pasteurella multocida A:3,4 to phagocytosis by turkey macrophages and heterophils, Am, J, Vet, Res, 52: 1507.Google Scholar
  59. Hensel, A., Pabst, R., Bunka, S., and Petzoldt, K., 1994, Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: Antibody response to capsular polysaccharide in bronchoalveolar lavage fluids (BALF) and sera of pigs, Clin, Exp, Immunol, 96: 91.CrossRefGoogle Scholar
  60. Inzana, T.J., 1990, Capsules and virulence of the HAP group bacteria, Can, J, Vet, Res, 54: S22.Google Scholar
  61. Inzana, T.J., Clark, G.F., and Todd, J., 1990, Detection of serotype-specific antibodies or capsular antigen of Actinobacillus pleuropneumoniae by a double-label radioimmunoassay, J, Clin, Microbiol, 28: 312.Google Scholar
  62. Inzana, T.J., Gogolewski, R.P., and Corbeil, L.B., 1992a, Phenotypic phase variation in Haemophilus somnus lipooligosaccharide during bovine pneumonia and after in vitro passage, Infect, Immun, 60: 2943.Google Scholar
  63. Inzana, T.J., Todd, J., Kock, C., and Nicolet, J., 1992b, Serotype specificity of immunological assays for the capsular polymer Actinobacillus pleuropneumoniae serotype I and 9, Vet, Microbiol, 31: 351.CrossRefGoogle Scholar
  64. Inzana, T.J., and Todd, J., 1992, Immune response of cattle to Haemophilus somnus lipid A-protein conjugates vaccine and efficacy in a mouse abortion model, Am, J, Vet, Res, 53: 175.Google Scholar
  65. Inzana, T.J., Todd, J., and Veit, H.P., 1993, Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines, Infect, Immun, 61: 1682.Google Scholar
  66. Jacques, M., Lebrun, A., Foiry, B., Dargis, M., and Malouin, F., 1991, Effects of antibiotics on the growth and morphology of Pasteurella multocida, J, Gen, Microbiol, 137: 2663.CrossRefGoogle Scholar
  67. Jacques, M., Kobisch, M., Belanger, M., and Dugal, F., 1993, Virulence of capsulated and noncapsulated isolates of Pasteurella multocida and their adherence to porcine respiratory tract cells and mucus, Infect, Immun, 61: 4785.Google Scholar
  68. Jacques, M., Belanger, M., Diana, M.S., Dargis, M., and Malouin, F., 1994, Modulation of Pasteurella multocida capsular polysaccharide during growth under iron-restricted conditions and in vivo, J, Gen, Microbiol, 140: 263.Google Scholar
  69. Kroll, J.S., Loynds, B., Brophy, L.N., and Moxon, E.R., 1990, The bex locus in encapsulated Haemophilus influensae: a chromosomal region involved in capsule polysaccharide export, Mol, Microbiol, 4: 1853 (1990).Google Scholar
  70. Kumar, S., Breider, M.A., Corstvet, R.E., and Maddux, J.L., 1991, Effect of Pasteurella haemolvtica saline capsular extract of bovine pulmonary endothelial cells, Am, Vet, Res, 52: 1774.Google Scholar
  71. Kuratana, K., and Anderson, P., 1991, Host metabolites that phenotypically increase the resistance of Haemophilus influenzae type b to clearance mechanisms,.1, Infect, Dis, 163: 1073.CrossRefGoogle Scholar
  72. Lebrun, A., Caya, M., and Jacques, M., 1992, Effects of sub-MICs of antibiotics on cell surface characteristics and virulence of Pasteurella multocida, Antimicrob, Agents Chemother, 36: 2093.CrossRefGoogle Scholar
  73. Lee, M.D., Glisson, J.R., and Wooley, R.E., 1992, Factors affecting endotoxin release from the cell surface of avian strains of Paste urella multocida, Vet, Microbiol, 31: 369.CrossRefGoogle Scholar
  74. Maheswaran, S.K., Weiss, D.J., Kannan, M,S., Townsend, E.L., Reddy, K.R., Whiteley, L.O., and Srikumaran, S., 1992, Effects of Pasteurella haemolytica Al leukotoxin on bovine neutrophils: degranulation and generation of oxygen-derived free radicals, Vet, Immunol, Immunopath, 33: 51.Google Scholar
  75. Maheswaran, S.K., Kaman, M.S., Weiss, D.J., Reddy, K.R., Townsend, E.L., Yoo, H.S., Lee, B.W., and Whiteley, L.O., 1993, Enhancement of neutrophil-mediated injury to bovine pulmonary endothelial cells by Pasteurella haemolytica leukotoxin, Infect, Immun, 61: 2618.Google Scholar
  76. Mandrel], R.E., and Apicella, M.A., 1993, Lipooligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host modification of LOS, Immunobiology 187: 382.CrossRefGoogle Scholar
  77. McCluskey, J., Gibbs, H.A., and Davies, R.L., 1994, Variation in outer-membrane protein and lipopolysaccharide profiles of Pasteurella haemolytica isolates of serotype Al and A2 obtained from pneumonic and healthy cattle, J, Gen, Microbiol, 140: 807.CrossRefGoogle Scholar
  78. McDermott, C.M., and Fenwick, B.W., 1992, Mechanisms Responsible for Increases in Bovine Neutrophil Acyloxyacyl Hydrolase (AOAH) Activity During Inflammation, Am, J, Vet, Res, 53: 803.Google Scholar
  79. Melaugh, W., Phillips, N.J., Campagnari, A.A., Karalus, R., Gibson, B.W., 1992, Partial characterization of the major lipooligosaccharide from a strain of Haemophilus ducreyi, the causative agent of chancroid, a genital ulcer disease, J, Biol, Chem, 267: 13434.Google Scholar
  80. Mertsola, J., Cope, L.D., Saez Llorens, X., Ramilo, O., Kennedy, W., McCracken Jr., G.H., and Hansen, E.J., 1991, In vivo and in vitro expression of Haemophilia influe n:ae type b lipooligosaccharide epitopes, J, Infect, Dis, 164: 555.CrossRefGoogle Scholar
  81. Nakai, T., Kawahara, K., Danbara, H., and Kume, K., 1991, The epitope structure in lipopolysaccharide recognized by the serotype 2-specific monoclonal antibody of Actinobacillus pleuropneumoniae, FEMS Microbiol, Lett, 82: 143.CrossRefGoogle Scholar
  82. Nakai, T., Kawahara, K., Danbara, H., and Kume, K., 1992, Identification of the cross-reacting antigen among Actinobacillus pleuropneumoniae strains of serotype 1, 9, and 11 by use of monoclonal antibodies, J, Vet, Med, Sci, 54: 707.CrossRefGoogle Scholar
  83. Patrick, C.C., Pelzel, S.E., Miller, E.E., Haanes-Fritz, E., Radolf, J.D., Gulig, P.A., McCracken Jr, G.H., and Hansen, E.J., 1989, Antigenic evidence for simultaneous expression of two different lipooligosaccharides by some strains of llaemophilus influen:ae type b, Infect, Immun, 57: 1971.Google Scholar
  84. Paulsen, D.B., Mosier, D.A., Clinkenbeard, K.D., and Confer, A.W., 1989, Direct effects of Pasteurella haemolytica lipopolysaccharide on bovine pulmonary endothelial cells in vitro, Am.1, Vet, Res, 50: 1633.Google Scholar
  85. Paulsen, D.B., Confer, A.W., Clinkenbeard, K.D., and Mosier, D.A., 1990, Pasteurella haemolytica lipopolysaccharide-induced arachidonic acid release from and neutrophil adherence to bovine pulmonary artery endothelial cells, Am.1, Vet, Res, 51: 1635.Google Scholar
  86. Perry, M.B., 1990, Structural analysis of the lipopolysaccharide of Actinobacillus (Haemophilus) pleuropneumoniae serotype 10, Biochem, Cell, Biol, 68: 808.CrossRefGoogle Scholar
  87. Read, R.C., Rutman, A.A., Jeffery, P.K., Lund V.J., Brain A.P., Moxon, E.R., Cole, P.J., and Wilson,R., 1992, Interaction of capsulate Haemophilus influer:ere with human airway mucosa in vitro, Infect, Immun, 60: 3244 (1992).Google Scholar
  88. Richards, J.C., and Leitch, R.A., 1989, Elucidation of the structure of the Pasteurella haemolytica serotype TIO lipopolysaccharide 0-antigen by n.m.r, spectroscopy, Carbohydr, Res, 186: 275.CrossRefGoogle Scholar
  89. Rimler, R.B., 1990, Comparisons of Pasteurella multocida lipopolysaccharides by sodium dodecyl sulfatepolyacrylamide gel electrophoresis to determine relationship between group B and E hemorrhage septicemia strains and serologically related group A strains, J, Clin, Microbiol, 28: 654.Google Scholar
  90. Rimler, R.B., 1994, Presumptive identification of Pasteurella multocida serogroups A, D, and F by capsule depolymerisation with mucopolysaccharidases, Vet, Rec, 134: 191.CrossRefGoogle Scholar
  91. Rosendal, S., and Machines, J.I., 1990, Characterization of an attenuated strain of Actinobacillus pleuropneumoniae, serotype 1, Am, J, Vet, Res, 51: 711.Google Scholar
  92. Rubin, L.G., and St, Geme, J.W., 1993, Role of lipooligosaccharide in virulence of the Brazilian purpuric fever clone of Haemophilus influen:ae biogroup aegyptius for infant rats, infect, Immun, 61: 650.Google Scholar
  93. Sato, S., Takamatsu, N., Okahashi, N., Matsunoshita, N., Inoue, M., Takehara, T., and Koga., T, 1992, Construction of mutants of Actinobacillus actinotnycetemcomitans defective in serotype b-specific polysaccharide antigen by insertion of transponson Tn916.1, Gen, Microbiol, 138: 1203.CrossRefGoogle Scholar
  94. Schweda, E.K.H., Sundstrom, A.C., Eriksson, L.M., Jonasson, J.A., and Lindberg, A.A., 1994, Structural studies of the cell envelope lipopolysaccharides from Haemophilus ducreyi strains ITM 2665 and ITM 4747, J, Biol, Chem, 269: 1 2040.Google Scholar
  95. Severn, W.B., and Richards, J.C., 1993, Characterization of the 0-polysaccharide of Pasteurella haemolytica serotype Al, Carbohydr, Res, 240: 277.CrossRefGoogle Scholar
  96. Sharma, S.A., Olchowy, T.W., Yang, Z., and Breider, M,A., 1992, Tumor necrosis factor alpha and interleukin 1 alpha enhance lipopolysaccharide-mediated bovine endothelium cell injury, J, Leuk, Biol, 51: 579.Google Scholar
  97. Slocombe, R.F., Mulks, M., Killingsworth, C.R., Derksen, F.J., and Robinson, N.E., 1990, Effect of Pasteurella haemolytica-derived endotoxin on pulmonary structure and function in calves, Am, J, Vet, Res, 51: 433.Google Scholar
  98. Spinola, S.M., Kwaik, Y.A., Lesse, A.J., Campagnari, A.A., and Apicella, M.A., 1990, Cloning and expression in Escherichia coli of a Haemophilus influenzae type b lipooligosaccharide synthesis gene(s) that encodes 2-keta-3-deoxyoctulosonic acid epitope, Infect, Immun, 58: 1558.Google Scholar
  99. St, Gerne, J.W., and Falkow, S., 1991, Loss of capsule expression by Haemophilus influenzae type b results in enhanced adherence to and invasion of human cells, Infect, Imun, 59: 1325.Google Scholar
  100. Steffens, W.L., Byrd, W., and Kadis, S., 1990, Identification and localization of surface sialyated glycoconjugates in Actinobacillus pleuropneu noniae by direct enzyme-colloidal gold cytochemistry, Vet, Microbiol, 25: 217.CrossRefGoogle Scholar
  101. Sutherland, A.D., Davies, R.C., and Murray, J., 1993, An experimental anti-idiotype vaccine mimicking lipopolysaccharide give protection against Pasteurella multocida, FEMS Immunol, Med, Microbiol, 7: 105.CrossRefGoogle Scholar
  102. Swift, A.J., Moxon E.R., Zwahlen, A., and Winkelstein, J.A., 1991, Complement-mediated serum activities against genetically defined capsular transformants of Haemophilus influenzae, Microb, Pat hog, 10: 261.CrossRefGoogle Scholar
  103. Tsai, C.M., Gu, X.X., and Byrd, R.A., 1994, Quantification of polysaccharide in Haemophilus influenzae type b conjugate and polysaccharide vaccines by high-performance anion-exchange chromatography with pulsed amperometric detection, Vaccine 12: 700.PubMedCrossRefGoogle Scholar
  104. Tsuji, M., and Matsumoto, M., 1989, Pathogenesis of fowl cholera: influence of encapsulation of the fate of Pasteurella multocida after intravenous inoculation into turkeys, Avian Dis, 33: 238.PubMedCrossRefGoogle Scholar
  105. Utley, S.R., Bhat, U.R., Byrd, W., and Kadis, S., 1992, Characterization of lipopolysaccharides for four Pasteurella haemolytica serotype strains, evidence for presence of sialic acid in serotypes 1 and 5, FEMS Microbiol, Lett, 92: 211.CrossRefGoogle Scholar
  106. Virji, M., Kayhty, H., Ferguson, D.J., Alexandrescu, C., and Moxon, E.R., 1991, Interaction of Haemophilus influenzae with cultured human endothelial cells, Microb, Pathog, 10: 231.CrossRefGoogle Scholar
  107. Ward, C.K., and Inzana, T.J., 1993, Cloning of a DNA region putatively involved in the encapsulation of Actinobacillus pleuropneumoniae, Proc, Conf, Res, Works Animal Dis, 74: 44.Google Scholar
  108. Whiteley, L.O., Maheswaran, S.K., Weiss, D.J., and Ames, T.R., 1990, immunohistochemical localization of Pasteurella haemolytica A I-derived endotoxin, leukotoxin and capsular polysaccharide in experimental bovine pasteurella pneumonia, Vet, Path, 27: 150.Google Scholar
  109. Wilson, C.F., Sutherland, A.D., Inglis, L., and Donachie, W., 1992, Characterization and biological activity of monoclonal antibodies specific for Pasteurella haemolytica A 1 capsule and lipopolysaccharide, Vet, Microbiol, 31: 161.CrossRefGoogle Scholar
  110. Zwahlen A., Kroll, J.S., Rubin, L.G., and Moxon, E.R., 1989, The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes at the capsulation locus cap, Microb, Pathog, 7: 225.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • B. Fenwick
    • 1
  1. 1.Department of Pathology & Microbiology College of Veterinary MedicineKansas State UniversityManhattanUSA

Personalised recommendations